mk 912 has been researched along with rutecarpine in 1 studies
Studies (mk 912) | Trials (mk 912) | Recent Studies (post-2010) (mk 912) | Studies (rutecarpine) | Trials (rutecarpine) | Recent Studies (post-2010) (rutecarpine) |
---|---|---|---|---|---|
12 | 0 | 8 | 235 | 1 | 125 |
Protein | Taxonomy | mk 912 (IC50) | rutecarpine (IC50) |
---|---|---|---|
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.23 | |
Cytochrome P450 1A1 | Homo sapiens (human) | 0.26 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.022 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 8.7 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.29 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.055 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
1 other study(ies) available for mk 912 and rutecarpine
Article | Year |
---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |